DHODH and acute myeloid leukemia: To this end, clinical trials investigating the efficacy of DHODH inhibition have been reported for AML (ClinicalTrials.gov: NCT03404726), advanced lymphoma (ClinicalTrials.gov: NCT03834584), and recurrent glioma (ClinicalTrials.gov: NCT05061251).